CBD for Dogs: What Current Veterinary Research Can and Cannot Tell Us

The evidence on CBD for dogs is mixed and still limited. What peer-reviewed research says about safety, efficacy, drug interactions, and quality — and how to opt out of CBD product recommendations.

Published

Mar 30, 2026

Updated

Mar 30, 2026

References

5 selected

What CBD is (and what it isn't)

CBD (cannabidiol) is one of over a hundred cannabinoids found in the cannabis plant. It is not THC. CBD does not produce the psychoactive “high” associated with marijuana. In the pet product market, CBD is typically extracted from hemp (Cannabis sativa with less than 0.3% THC by dry weight).

The mechanism of interest is the endocannabinoid system (ECS), which dogs share with humans and other mammals. The ECS includes receptors (CB1, CB2) distributed throughout the brain, nervous system, and immune system. CBD interacts with this system, though not by binding directly to cannabinoid receptors the way THC does. The precise pathways by which CBD might affect anxiety-related behavior in dogs are still being studied.

CBD is not the same as “hemp”

This distinction matters. Many calming supplements marketed as “hemp” products use hemp seed oil or hemp powder. Hemp seeds contain little to no CBD. A product labeled “hemp calming chew” may deliver zero meaningful cannabidiol.

CBD products, by contrast, use extracts from the hemp plant's flowers and leaves where cannabinoids concentrate. If a product does not specify CBD content in milligrams, it is likely a hemp-seed product, not a CBD product. The two have different regulatory profiles, different active compound profiles, and different clinical relevance.

Key takeaway

CBD (cannabidiol) is a specific compound, not a synonym for hemp. Many “hemp calming chews” contain no meaningful CBD. Check for milligram-level CBD content on the label.

What the evidence says

The honest summary: short-term tolerability looks reasonable in most studies, but the behavioral efficacy evidence is thinner, more variable, and harder to generalize than many product pages suggest.

This is not “nobody knows anything.” There is real research. But it is also not “CBD is proven to help anxious dogs.” The evidence sits in the middle, and being honest about that is more useful than overstating either direction.

Safety and tolerability

Generally favorable in short-term studies, with caveats.

Most canine CBD studies report that dogs tolerate CBD reasonably well in the short term. The most common side effects are gastrointestinal (soft stool, decreased appetite). However, CBD can elevate alkaline phosphatase (ALP), a liver enzyme, and longer-term safety data remain limited. A 2023 review (PMC10347378) noted that while tolerability findings have been “generally favorable,” the available safety data are still based on relatively small sample sizes and short durations.

Behavioral efficacy: the harder question

Limited and mixed. Three clinical behavioral studies as of 2023.

Most published canine CBD research focuses on osteoarthritis and pain, not behavior. The same 2023 review identified only three clinical studies examining CBD for behavioral outcomes in dogs — one reported positive results, one mixed, and one negative. That is not enough to draw confident conclusions in either direction.

A separate systematic review and meta-analysis (PMC10540436), focused on osteoarthritis, found a possible benefit but rated the certainty of evidence as “very low.” That assessment of evidence quality is worth noting even though it covers a different condition — it reflects where the field is overall in terms of rigor.

Acute stress: one promising but narrow result

Benefit for separation/car-travel stress in one study, with author cautions.

A 2023 study (PMC9992179) found some benefit from a single oral dose of CBD for dogs experiencing acute separation and car-travel stress. That is a genuine positive finding. However, the study authors cautioned against generalizing their results to CBD products as a broad category — formulation, dosing, and product quality all vary. One well-designed study is a start, not proof that any CBD product will help any anxious dog.

Combination products: mild effects, high variability

Cortisol-lowering effect observed, but individual response varied widely.

A 2025 crossover study (PMC12339541) tested treats combining CBD with L-tryptophan and α-casozepine. The study found a mild stress-reducing effect as measured by cortisol, but the individual variability was high — some dogs responded, others did not. This pattern of “mild average effect with wide individual variation” is common in the nutraceutical literature and underscores why one dog's experience may not predict another's.

Key takeaway

Short-term tolerability is generally reasonable. Behavioral efficacy is more debatable — the evidence base is small, mixed, and product-specific. Owners considering CBD should understand these limits rather than relying on marketing claims.

Quick assessment

One specific episode is enough to start spotting the pattern.

Start with when it happened, what set it off, and how your dog reacted. Scout uses that episode to sort the pattern fast and build from something real, not from general advice.

Tell Scout about the last episode →

Drug interactions and contraindications

CBD is metabolized by the liver, primarily through cytochrome P450 enzymes. This means it can interact with other drugs that use the same metabolic pathways. In practice, this is one of the more important safety considerations.

Liver enzyme elevation

Studies have documented elevated alkaline phosphatase (ALP) in dogs receiving CBD. While this is not necessarily harmful on its own, it warrants monitoring — especially in dogs with pre-existing liver conditions or those on hepatically-processed medications.

Medications to discuss with your vet

If your dog takes anti-seizure medications, NSAIDs, certain heart medications, or any drug metabolized by the liver, talk to your veterinarian before adding CBD. The interaction potential is not theoretical — it is based on known metabolic pathways.

Pregnancy and nursing

CBD has not been studied in pregnant or nursing dogs. Avoid use in these populations until safety data exist.

Key takeaway

CBD is processed by the liver and can interact with other medications. Any dog already on medication should be evaluated by a veterinarian before starting CBD.

Quality and what to look for

Because CBD pet products are not FDA-approved, quality varies dramatically across the market. Some products contain less CBD than the label claims. Some contain contaminants. A few contain detectable THC above labeled amounts. The burden of quality verification falls on the buyer.

Certificate of Analysis (COA)

A COA from an independent, third-party laboratory is the single most important quality signal. It should verify the CBD content matches the label, confirm THC is below the legal threshold (0.3%), and screen for contaminants such as heavy metals, pesticides, and residual solvents. If a brand does not publish batch-specific COAs, move on.

Extraction method

CO2 extraction is generally regarded as the cleanest method. Solvent-based extraction (ethanol, butane) can leave residues if not properly purged. The extraction method should be disclosed.

Full-spectrum, broad-spectrum, and isolate

Full-spectrum contains other cannabinoids and trace THC. Broad-spectrum removes THC but retains other compounds. Isolate is pure CBD. The “entourage effect” theory suggests full-spectrum may be more effective, but this has not been conclusively demonstrated in dogs. For owners concerned about any THC exposure, broad-spectrum or isolate may be preferable.

Milligram dosing, not vague labels

A legitimate CBD product lists the total CBD content in milligrams and provides per-serving milligram dosing, ideally with a weight-based chart. Products that say “contains hemp extract” without specifying CBD in milligrams are not providing enough information to dose accurately.

Key takeaway

A third-party COA is non-negotiable. Without it, you cannot verify CBD content, THC levels, or contaminant screening. If a brand does not publish one, do not buy it.

Regulatory status

The regulatory landscape for CBD pet products is unsettled. Here is what that means in practice.

FDA position

The FDA has not approved any CBD product for use in animals. The agency has issued warning letters to companies making unsubstantiated health claims about CBD products for pets. CBD pet products are sold as supplements, not drugs, and are not subject to the same pre-market testing and approval requirements as veterinary pharmaceuticals.

State-by-state variation

While hemp-derived CBD (under 0.3% THC) is legal at the federal level following the 2018 Farm Bill, some states have additional restrictions on CBD in animal products. Veterinary legality also varies — in some states, veterinarians can discuss CBD with clients; in others, the rules are more restrictive.

What this means for buyers

The regulatory gap means there is no federal agency verifying that a CBD pet product contains what it says, is free from contaminants, or is effective. This is why third-party testing and COAs matter more for CBD products than for most other supplement categories.

Key takeaway

The FDA has not approved CBD for animals. CBD pet products are not subject to the same oversight as veterinary drugs. This makes third-party testing and informed skepticism essential.

Alternatives if you want to avoid CBD products

Some owners prefer to avoid CBD entirely — because of the regulatory uncertainty, the limited behavioral evidence, drug interaction concerns, or personal preference. That is a reasonable position. There are non-CBD calming options with their own evidence profiles.

On Pawsd, that preference hides products in the CBD categories (CBD oils and CBD chews). Some non-CBD calming products may still include hemp ingredients.

Amino acid and peptide blends

Product-specific evidence, some canine data.

Products containing L-theanine, L-tryptophan, or α-casozepine (a milk-derived peptide) have published canine studies. Evidence is product-specific rather than universal, but this ingredient class avoids the regulatory and interaction issues associated with CBD.

Gut-brain axis (probiotics)

Emerging area with promising mechanism.

Research on the gut-brain connection in dogs (PMC10827376) points to the microbiome as a factor in anxiety. Specific probiotic strains are being studied for behavioral effects. This is an emerging area — not yet settled science, but a different approach that avoids cannabinoid-related concerns.

Environmental and behavioral tools

Non-supplement approaches.

Pressure wraps, pheromone products, enrichment tools, and behavior modification are all non-supplement strategies. For some dogs, these work better than any supplement. For others, they work alongside supplements. Our calming supplements guide covers the full range of ingredient categories and matching strategies.

Not sure which direction fits your dog? Scout can help narrow the options based on your dog's anxiety pattern and your preferences — including whether you want to include or exclude CBD products.

Key takeaway

Non-CBD calming options exist across multiple categories: amino acid blends, probiotics, pheromones, pressure wraps, and behavior modification. Choosing to avoid CBD does not mean choosing to do nothing.

Your choice, respected

Pawsd does not assume every owner is comfortable with CBD, and we do not push CBD products as defaults. When you use Scout, you can choose whether to show or hide CBD products. Hiding CBD products removes CBD oils and CBD chews from recommendations and shop surfaces. Both paths produce a complete calming plan.

If you include CBD, Scout selects from products that publish third-party COAs and provide milligram-level dosing. If you exclude CBD, Scout builds your plan from non-CBD alternatives — amino acid blends, probiotics, environmental tools, and behavioral strategies. Some non-CBD calming products may still include hemp ingredients. Neither path is presented as superior. The right choice depends on your dog, your vet's input, and your comfort level.

The purpose of this guide is to give you enough information to make that decision with your eyes open — not to make it for you.

Frequently asked questions

Is CBD safe for dogs?

Short-term tolerability studies have generally been favorable, with mild gastrointestinal effects as the most common finding. However, CBD can elevate liver enzymes, longer-term data are limited, and dogs on other medications face interaction risks. Consult your veterinarian before starting CBD.

Is CBD the same as hemp?

No. Hemp seed oil and hemp powder contain little to no CBD. CBD is a specific cannabinoid extracted from hemp flowers and leaves. A product labeled “hemp calming chew” without milligram CBD content is likely not a CBD product.

Has the FDA approved CBD for dogs?

No. The FDA has not approved any CBD product for use in animals. CBD pet products are sold as supplements and are not subject to the same pre-market testing as veterinary drugs.

Does CBD actually help with dog anxiety?

The evidence is mixed. As of 2023, only three clinical behavioral studies in dogs have been identified in review literature — with results ranging from negative to positive. One study found benefit for acute separation and car-travel stress, but the authors cautioned against broad generalization. CBD may help some dogs in some contexts, but it is not a proven category-wide treatment for canine anxiety.

What can I give my dog instead of CBD?

Non-CBD options include amino acid and peptide blends (L-theanine, L-tryptophan, α-casozepine), probiotic products targeting the gut-brain axis, pheromone diffusers and sprays, pressure wraps, and structured behavior modification. See our calming supplements guide for a full comparison.

Evidence-informed guide

Pawsd guides are educational and not a substitute for veterinary advice. These pages draw from selected open-access peer-reviewed veterinary research, with full-text sources linked below.

Selected references

Pharmacokinetics, efficacy, and safety of cannabidiol in dogs: an update of current knowledge.

Front Vet Sci. 2023;10:1204526. PMCID: PMC10347378. Open-access review.

Systematic review and meta-analysis of cannabidiol for canine osteoarthritis.

Front Vet Sci. 2023;10:1252369. PMCID: PMC10540436. Open-access systematic review/meta-analysis.

Effect of a single oral dose of cannabidiol on acute separation and car-travel stress in dogs.

Front Vet Sci. 2023;10:1112604. PMCID: PMC9992179. Open-access study.

Gut-Brain Axis Impact on Canine Anxiety Disorders: New Challenges for Behavioral Veterinary Medicine.

Vet Med Int. 2024;2024:2856759. PMCID: PMC10827376. Open-access review.

Treats containing cannabidiol, L-tryptophan and α-casozepine have a mild stress-reducing effect in dogs.

Front Vet Sci. 2025;12:1632868. PMCID: PMC12339541. Open-access crossover study.

This guide is general. Your dog's last episode isn't.

Tell Scout about the most recent hard moment: when it happened, what set it off, and how your dog reacted. That is enough to start tracking the pattern and organize next steps.

Tell Scout about the last episode →

Related Reading

This guide contains affiliate links. If you purchase through our links, we may earn a small commission at no cost to you.